- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
December 5, 2024Jake Holdreith Named to Twin Cities Business Top 100
-
December 4, 2024Robins Kaplan Obtains $10.5 Million Post-Verdict in Landmark Aerosol Dust Remover Abuse Case
-
December 2, 2024Robins Kaplan LLP Announces 2025 Partners
-
December 12, 2024Strategies for Licensing AI: A Litigation Perspective
-
December 11, 20242024 Year in Review: eDiscovery and Artificial Intelligence
-
December 4, 2024Trust & Estate Litigation in Minnesota
-
December 2024A Landmark Victory for Disabled Homeless Veterans: Q&A with the Trial Team
-
November 8, 2024Trademark tensions on the track: Court upholds First Amendment protections in Haas v. Steiner
-
November 8, 2024Destination Skiing And The DOJ's Mountain Merger Challenge
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Consumer Alert: Guidant Defibrillators Recalled
On Friday, June 17, Guidant announced a recall of the Ventak Prizm 2 and additional model ICD's.
June 20, 2005
According to news reports, several models of Guidant Cardioverter Defibrillators may have flaws that could cause them to short-circuit and malfunction and cause injury or death. Last month, Guidant disclosed that there were electrical problems with its Ventak Prizm 2 Defibrillators, of which approximately 24,000s have been implanted in persons worldwide. On Friday, June 17, Guidant announced a recall of the Ventak Prizm 2 and additional model ICD's. The Guidant recall includes:
- VENTAK PRIZM 2 DR (Model 1861) ICDs manufactured on or before April 16, 2002.
- CONTAK RENEWAL (Model H135) and CONTAK RENEWAL 2 (Model H155) CRT-Ds manufactured on or before August 26, 2004.
- VENTAK PRIZM AVT, VITALITY AVT, RENEWAL 3 AVT and RENEWAL 4 AVT ICDs (All series numbers).
The manufacturer, Guidant Corporation, is headquartered in St. Paul Minnesota.
Guidant Cardioverter Defibrillators (ICD) are implanted devices that detect abnormal heart rhythms (ventricular arrhythmias) and shock the heart back to a normal rate. The devices consists of a pulse generator (a battery and electronic circuitry) connected to one or two insulated wires (leads). The pulse generator is usually implanted under the collarbone, just beneath the skin. The main lead is inserted into the lower right heart chamber (the right ventricle). A second lead may be placed in the upper right heart chamber (the right atrium).
If you or your loved one is implanted with the Guidant Ventak Implantable Cardioverter Defibrillator that has experienced a short circuit, and you wish to consult with us, please call Tara Sutton at 612-349-8577 (or call 1-800-553-9910). You can also send an e-mail by clicking here: contact us.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.